PAYLESS COMPOUNDERS, LLC is recalling 91 vials of Semaglutide-Glycine-Cyanocobalamin Injectable (brand name Northwest Compounders) due to a lack of assurance of sterility. Using a non-sterile injectable medication can lead to serious or life-threatening infections at the injection site or in the bloodstream. The affected products include 0.5 mL vials in 2.5 mg and 5 mg strengths, primarily distributed in Oregon.
The lack of sterility assurance means the injectable medication may contain microorganisms that could cause serious infections or other health complications if administered.
You have 2 options:
Rx only
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.